Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge

Journal of Immunology

Volumn 194, Issue 4, 2015, Pages 1609-1620

  Cabrera Perez, Javier ^a   Condotta, Stephanie A ^b   James, Britnie R ^c   Kashem, Sakeen W ^a   Brincks, Erik L ^c   Rai, Deepa ^b   Kucaba, Tamara A ^c   Badovinac, Vladimir P ^b   Griffith, Thomas S ^a,c,d,e  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CANDIDIASIS; CD4+ T LYMPHOCYTE; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; LISTERIOSIS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRE T LYMPHOCYTE; SEPSIS; THYMUS; ADOPTIVE TRANSFER; ANIMAL; BACTERIAL INFECTION; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; BACTERIAL INFECTIONS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; PRECURSOR CELLS, T-LYMPHOID; SEPSIS; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 84922570656     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401711     Document Type: Article

References (81)

1. Pepper, M., and M. K. Jenkins. 2011. Origins of CD4(+) effector and central memory T cells. Nat. Immunol. 12: 467-471.
2. Green, A. M., R. Difazio, and J. L. Flynn. 2013. IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobac-terium tuberculosis infection. J. Immunol. 190: 270-277.
3. Phares, T. W., S. A. Stohlman, D. R. Hinton, and C. C. Bergmann. 2012. Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis. J. Neuroinflammation 9: 269.
4. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434: 88-93.
5. Badovinac, V. P., K. A. Messingham, T. S. Griffith, and J. T. Harty. 2006. TRAIL deficiency delays, but does not prevent, erosion in the quality of "helpless" memory CD8 T cells. J. Immunol. 177: 999-1006.
6. Sacks, J. A., and M. J. Bevan. 2008. TRAIL deficiency does not rescue impaired CD8+ T cell memory generated in the absence of CD4+ T cell help. J. Immunol. 180: 4570-4576.
7. Church, S. E., S. M. Jensen, P. A. Antony, N. P. Restifo, and B. A. Fox. 2014. Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells. Eur. J. Immunol. 44: 69-79.
8. Weinstein, J. S., S. G. Hernandez, and J. Craft. 2012. T cells that promote B-Cell maturation in systemic autoimmunity. Immunol. Rev. 247: 160-171.
9. Yates, J. L., R. Racine, K. M. McBride, and G. M. Winslow. 2013. T cell-dependent IgM memory B cells generated during bacterial infection are required for IgG responses to antigen challenge. J. Immunol. 191: 1240-1249.
10. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
11. Hall, M. J., S. N. Williams, C. J. DeFrances, and A. Golosinskiy. 2011. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS Data Brief: 1-8.
12. Angus, D. C. 2011. The search for effective therapy for sepsis: back to the drawing board? JAMA 306: 2614-2615.
13. 1992. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20: 864-874.
14. Levy, M. M., M. P. Fink, J. C. Marshall, E. Abraham, D. Angus, D. Cook, J. Cohen, S. M. Opal, J. L. Vincent, and G. Ramsay. 2003. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31: 1250-1256.
15. Brun-Buisson, C. 2000. The epidemiology of the systemic inflammatory response. Intensive Care Med. 26(Suppl. 1): S64-S74.
16. Hotchkiss, R. S., G. Monneret, and D. Payen. 2013. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13: 260-268.
17. Unsinger, J., H. Kazama, J. S. McDonough, T. S. Griffith, R. S. Hotchkiss, and T. A. Ferguson. 2010. Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism. J. Immunol. 184: 6766-6772.
18. Roger, P. M., H. Hyvernat, M. Ticchioni, G. Kumar, J. Dellamonica, and G. Bernardin. 2012. The early phase of human sepsis is characterized by a combination of apoptosis and proliferation of T cells. J. Crit. Care 27: 384-393.
19. Unsinger, J., H. Kazama, J. S. McDonough, R. S. Hotchkiss, and T. A. Ferguson. 2009. Differential lymphopenia-induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury. J. Leukoc. Biol. 85: 382-390.
20. Moon, J. J., H. H. Chu, J. Hataye, A. J. Pagán, M. Pepper, J. B. McLachlan, T. Zell, and M. K. Jenkins. 2009. Tracking epitope-specific T cells. Nat. Protoc. 4: 565-581.
21. Rittirsch, D., M. S. Huber-Lang, M. A. Flierl, and P. A. Ward. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4: 31-36.
22. Pepper, M., A. J. Pagán, B. Z. Igyártó, J. J. Taylor, and M. K. Jenkins. 2011. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 35: 583-595.
23. Igyártó, B. Z., K. Haley, D. Ortner, A. Bobr, M. Gerami-Nejad, B. T. Edelson, S. M. Zurawski, B. Malissen, G. Zurawski, J. Berman, and D. H. Kaplan. 2011. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35: 260-272.
24. Griffith, T. S., J. M. Herndon, J. Lima, M. Kahn, and T. A. Ferguson. 1995. The immune response and the eye. TCR alpha-chain related molecules regulate the systemic immunity to antigen presented in the eye. Int. Immunol. 7: 1617-1625.
25. Brincks, E. L., P. Gurung, R. A. Langlois, E. A. Hemann, K. L. Legge, and T. S. Griffith. 2011. The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL. J. Immunol. 187: 4581-4588.
26. Brincks, E. L., A. D. Roberts, T. Cookenham, S. Sell, J. E. Kohlmeier, M. A. Blackman, and D. L. Woodland. 2013. Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection. J. Immunol. 190: 3438-3446.
27. BenMohamed, L., G. Bertrand, C. D. McNamara, H. Gras-Masse, J. Hammer, S. L. Wechsler, and A. B. Nesburn. 2003. Identification of novel immunodo-minant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus gly-coprotein D that confer protective immunity. J. Virol. 77: 9463-9473.
28. Crowe, S. R., S. C. Miller, D. M. Brown, P. S. Adams, R. W. Dutton, A. G. Harmsen, F. E. Lund, T. D. Randall, S. L. Swain, and D. L. Woodland. 2006. Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine 24: 457-467.
29. Moon, J. J., H. H. Chu, M. Pepper, S. J. McSorley, S. C. Jameson, R. M. Kedl, and M. K. Jenkins. 2007. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27: 203-213.
30. Pagán, A. J., M. Pepper, H. H. Chu, J. M. Green, and M. K. Jenkins. 2012. CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs. J. Immunol. 189: 2909-2917.
31. Nelson, R. W., J. B. McLachlan, J. R. Kurtz, and M. K. Jenkins. 2013. CD4+ T cell persistence and function after infection are maintained by low-level peptide: MHC class II presentation. J. Immunol. 190: 2828-2834.
32. Chu, H. H., J. J. Moon, A. C. Kruse, M. Pepper, and M. K. Jenkins. 2010. Negative selection and peptide chemistry determine the size of naive foreign peptide-MHC class II-specific CD4+ T cell populations. J. Immunol. 185: 4705-4713.
33. Gurung, P., D. Rai, S. A. Condotta, J. C. Babcock, V. P. Badovinac, and T. S. Griffith. 2011. Immune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is TRAIL dependent. J. Immunol. 187: 2148-2154.
34. Condotta, S. A., D. Rai, B. R. James, T. S. Griffith, and V. P. Badovinac. 2013. Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection. J. Immunol. 190: 1991-2000.
35. Duong, S., S. A. Condotta, D. Rai, M. D. Martin, T. S. Griffith, and V. P. Badovinac. 2014. Polymicrobial sepsis alters antigen-dependent and - independent memory CD8 T cell functions. J. Immunol. 192: 3618-3625.
36. Fink, P. J. 2013. The biology of recent thymic emigrants. Annu. Rev. Immunol. 31: 31-50.
37. Sprent, J., and C. D. Surh. 2011. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat. Immunol. 12: 478-484.
38. Cho, B. K., V. P. Rao, Q. Ge, H. N. Eisen, and J. Chen. 2000. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J. Exp. Med. 192: 549-556.
39. Ernst, B., D. S. Lee, J. M. Chang, J. Sprent, and C. D. Surh. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11: 173-181.
40. McDermott, D. S., and S. M. Varga. 2011. Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think. J. Immunol. 187: 5568-5576.
41. Butler, N. S., J. Moebius, L. L. Pewe, B. Traore, O. K. Doumbo, L. T. Tygrett, T. J. Waldschmidt, P. D. Crompton, and J. T. Harty. 2012. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat. Immunol. 13: 188-195.
42. Alpdogan, O., S. J. Muriglan, J. M. Eng, L. M. Willis, A. S. Greenberg, B. J. Kappel, and M. R. van den Brink. 2003. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J. Clin. Invest. 112: 1095-1107.
43. McSorley, S. J., S. Asch, M. Costalonga, R. L. Reinhardt, and M. K. Jenkins. 2002. Tracking Salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. Immunity 16: 365-377.
44. Oxenius, A., M. F. Bachmann, R. M. Zinkernagel, and H. Hengartner. 1998. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28: 390-400.
45. Jenkins, M. K., and J. J. Moon. 2012. The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude. J. Immunol. 188: 4135-4140.
46. Lipsett, P. A. 2006. Surgical critical care: fungal infections in surgical patients. Crit. Care Med. 34(9, Suppl.)S215-S224.
47. Laing, K. J., L. Dong, J. Sidney, A. Sette, and D. M. Koelle. 2012. Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses. Clin. Exp. Immunol. 167: 47-58.
48. Gebhardt, T., P. G. Whitney, A. Zaid, L. K. Mackay, A. G. Brooks, W. R. Heath, F. R. Carbone, and S. N. Mueller. 2011. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature 477: 216-219.
49. Martin, M. D., S. A. Condotta, J. T. Harty, and V. P. Badovinac. 2012. Population dynamics of naive and memory CD8 T cell responses after antigen stimulations in vivo. J. Immunol. 188: 1255-1265.
50. Hernández-Santos, N., and S. L. Gaffen. 2012. Th17 cells in immunity to Candida albicans. Cell Host Microbe 11: 425-435.
51. Hernández-Santos, N., A. R. Huppler, A. C. Peterson, S. A. Khader, K. C. McKenna, and S. L. Gaffen. 2013. Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol. 6: 900-910.
52. Venet, F., O. Filipe-Santos, A. Lepape, C. Malcus, F. Poitevin-Later, A. Grives, N. Plantier, N. Pasqual, and G. Monneret. 2013. Decreased T-cell repertoire diversity in sepsis: a preliminary study. Crit. Care Med. 41: 111-119.
53. Iwashyna, T. J., G. Netzer, K. M. Langa, and C. Cigolle. 2012. Spurious inferences about long-term outcomes: the case of severe sepsis and geriatric conditions. Am. J. Respir. Crit. Care Med. 185: 835-841.
54. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, R. E. Schmieg, Jr., J. J. Hui, K. C. Chang, D. F. Osborne, B. D. Freeman, J. P. Cobb, T. G. Buchman, and I. E. Karl. 2001. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 166: 6952-6963.
55. Hotchkiss, R. S., and D. W. Nicholson. 2006. Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6: 813-822.
56. Badovinac, V. P., J. S. Haring, and J. T. Harty. 2007. Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity 26: 827-841.
57. Mazmanian, S. K., C. H. Liu, A. O. Tzianabos, and D. L. Kasper. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122: 107-118.
58. Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486: 207-214.
59. Sportès, C., F. T. Hakim, S. A. Memon, H. Zhang, K. S. Chua, M. R. Brown, T. A. Fleisher, M. C. Krumlauf, R. R. Babb, C. K. Chow, et al. 2008. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J. Exp. Med. 205: 1701-1714.
60. Surh, C. D., and J. Sprent. 2008. Homeostasis of naive and memory T cells. Immunity 29: 848-862.
61. Boyman, O., S. Létourneau, C. Krieg, and J. Sprent. 2009. Homeostatic proliferation and survival of naïve and memory T cells. Eur. J. Immunol. 39: 2088-2094.
62. Inoue, S., J. Unsinger, C. G. Davis, J. T. Muenzer, T. A. Ferguson, K. Chang, D. F. Osborne, A. T. Clark, C. M. Coopersmith, J. E. McDunn, and R. S. Hotchkiss. 2010. IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J. Immunol. 184: 1401-1409.
63. Unsinger, J., M. McGlynn, K. R. Kasten, A. S. Hoekzema, E. Watanabe, J. T. Muenzer, J. S. McDonough, J. Tschoep, T. A. Ferguson, J. E. McDunn, et al. 2010. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J. Immunol. 184: 3768-3779.
64. Unsinger, J., C. A. Burnham, J. McDonough, M. Morre, P. S. Prakash, C. C. Caldwell, W. M. Dunne, Jr., and R. S. Hotchkiss. 2012. Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J. Infect. Dis. 206: 606-616.
65. Dirks, J., A. Egli, U. Sester, M. Sester, and H. H. Hirsch. 2013. Blockade of programmed death receptor-1 signaling restores expression of mostly proin-flammatory cytokines in anergic cytomegalovirus-specific T cells. Transpl. Infect. Dis. 15: 79-89.
66. Chang, K., C. Svabek, C. Vazquez-Guillamet, B. Sato, D. Rasche, S. Wilson, P. Robbins, N. Ulbrandt, J. Suzich, J. Green, et al. 2014. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit. Care 18: R3.
67. Inoue, S., L. Bo, J. Bian, J. Unsinger, K. Chang, and R. S. Hotchkiss. 2011. Dose-dependent effect of anti-CTLA-4 on survival in sepsis. Shock 36: 38-44.
68. Brahmamdam, P., S. Inoue, J. Unsinger, K. C. Chang, J. E. McDunn, and R. S. Hotchkiss. 2010. Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis. J. Leukoc. Biol. 88: 233-240.
69. Zhang, Y., Y. Zhou, J. Lou, J. Li, L. Bo, K. Zhu, X. Wan, X. Deng, and Z. Cai. 2010. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit. Care 14: R220.
70. Mahon, B. P., K. Katrak, A. Nomoto, A. J. Macadam, P. D. Minor, and K. H. Mills. 1995. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J. Exp. Med. 181: 1285-1292.
71. Chen, F., Z. Liu, W. Wu, C. Rozo, S. Bowdridge, A. Millman, N. Van Rooijen, J. F. Urban, Jr., T. A. Wynn, and W. C. Gause. 2012. An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat. Med. 18: 260-266.
72. Cohen, J. M., S. Khandavilli, E. Camberlein, C. Hyams, H. E. Baxendale, and J. S. Brown. 2011. Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation. PLoS ONE 6: e25558.
73. Gouel-Chéron, A., F. Venet, B. Allaouchiche, and G. Monneret. 2012. CD4+ T-lymphocyte alterations in trauma patients. Crit. Care 16: 432.
74. Leng, F. Y., J. L. Liu, Z. J. Liu, J. Y. Yin, and H. P. Qu. 2013. Increased proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells during early-stage sepsis in ICU patients. J. Microbiol. Immunol. Infect. 46: 338-344.
75. Monneret, G., A. L. Debard, F. Venet, J. Bohe, O. Hequet, J. Bienvenu, and A. Lepape. 2003. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit. Care Med. 31: 2068-2071.
76. Venet, F., A. Pachot, A. L. Debard, J. Bohé, J. Bienvenu, A. Lepape, and G. Monneret. 2004. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit. Care Med. 32: 2329-2331.
77. Benjamim, C. F., S. K. Lundy, N. W. Lukacs, C. M. Hogaboam, and S. L. Kunkel. 2005. Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood 105: 3588-3595.
78. Fazal, N., S. Raziuddin, M. Khan, and W. M. Al-Ghoul. 2006. Antigen presenting cells (APCs) from thermally injured and/or septic rats modulate CD4+ T cell responses of naive rat. Biochim. Biophys. Acta 1762: 46-53.
79. Flohé, S. B., H. Agrawal, D. Schmitz, M. Gertz, S. Flohé, and F. U. Schade. 2006. Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response. J. Leukoc. Biol. 79: 473-481.
80. Muenzer, J. T., C. G. Davis, B. S. Dunne, J. Unsinger, W. M. Dunne, and R. S. Hotchkiss. 2006. Pneumonia after cecal ligation and puncture: a clinically relevant "two-hit" model of sepsis. Shock 26: 565-570.
81. Opal, S. M. 2010. New perspectives on immunomodulatory therapy for bacter-aemia and sepsis. Int. J. Antimicrob. Agents 36(Suppl. 2): S70-S73.